Skip to main content

Table 1 (a) Correlation between Datquant® and BasGanV2 SBR, ratio, and asymmetries and (b) correlation between MDS-UPDRS-III score and SBR, ratio, asymmetries achieved with Datquant® and BasGanV2

From: Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools

  Right caudate Left caudate Right putamen Left putamen Right P/C ratio Left P/C ratio Caudate asymmetry Putamen asymmetry
(a)
Datquant®/
BasGan V2
r = .771
p < .0001*
r = .752
p < .0001*
r = .866
p < .0001*
r = .847
p < .0001*
r = .793
p < .0001*
r = .706
p < .0001*
r = .887
p < .0001*
r = .783
p < .0001*
(b)
Datquant® /UPDRS-III  − .414
p = .0015*
 − .434
p = .0009*
 − .251
p = .0405
 − .282
p = .0248
.027
p = .4275
.095
p = .2573
.423
p = .0012*
.201
p = .0413
BasGan V2 /UPDRS-III  − .523
p = .0001*
 − .532
p = .0001*
 − .366
p = .0048*
 − .447
p = .0006*
 − .361
p = .0053*
.082
p = .2884
.277
p = .0268
.321
p = .0122
  1. In the columns, the values of SBR, P/C ratio, and asymmetry are reported. Asymmetries are computed without taking into account the side of the more affected hemisphere. See the text for abbreviations. Italics characters show statistically significant correlation (one-tail Pearson’s r), while * denotes those correlations surviving Bonferroni’s correction for multiple comparisons (p = .00625 as first level of statistical significance)